Overview of Myorisan (Isotretinoin)
Myorisan, with the National Drug Code (NDC) 61748-303, is a liquid-filled oral capsule containing isotretinoin, a retinoid used primarily for the treatment of severe acne. It is labeled and distributed by VersaPharm, Inc.[4].
Market Context
The pharmaceutical market is experiencing significant changes and growth. Here are some key points to consider:
General Market Growth
The overall prescription drug market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by various factors, including the expansion of indications for existing medications and the introduction of new therapies[3].
Drug Price Inflation
For 2025, the overall drug price inflation rate is estimated to be around 3.81%, according to Vizient's Pharmacy Market Outlook. This inflation is partly due to the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].
Pricing Trends for Isotretinoin
Current Pricing
As of the latest available data, the pricing for Myorisan (NDC 61748-303) is not explicitly provided in the sources. However, we can look at general trends in the market to make some inferences.
Historical Pricing Data
For other drugs, historical pricing data shows fluctuations based on market conditions, competition, and regulatory changes. For example, linezolid (NDC 00054-0319) has seen price variations over the past year, ranging from $1.69 to $1.95 per milliliter[3].
Regulatory Impact
The Centers for Medicare & Medicaid Services (CMS) requires manufacturers to report Average Sales Price (ASP) data for individual NDCs, which can influence pricing transparency and stability. This reporting helps in setting reimbursement rates and can impact the overall pricing strategy for drugs like Myorisan[5].
Price Projections for Myorisan
Short-Term Projections
Given the general trend of drug price inflation, it is reasonable to expect that the price of Myorisan could increase in the short term. A 3.81% inflation rate, as projected by Vizient, could translate to a similar increase in the price of Myorisan.
Long-Term Projections
Over the long term, the price of Myorisan may be influenced by several factors:
- Market Competition: The presence of generic versions of isotretinoin could keep prices in check.
- Regulatory Changes: Any changes in regulatory requirements or reporting standards could impact pricing.
- Demand and Supply: Changes in demand due to new treatment options or supply chain disruptions could also affect prices.
Example Calculation
If the current price of Myorisan is assumed to be around $X per capsule, a 3.81% increase would result in a new price of $X * 1.0381. This is a simplified example and actual prices may vary based on various market and regulatory factors.
Operational and Budgetary Considerations
Health System Impact
The introduction of high-cost therapies, although not directly related to Myorisan, highlights the need for health systems to manage their budgets and operational processes carefully. For drugs like Myorisan, which are part of standard treatment protocols, health systems need to ensure they have a long-term approach to manage costs and access to treatments[2].
Patient Access
Ensuring patient access to necessary medications like Myorisan is crucial. Health systems and providers must synchronize logistics and manage budgets to provide these treatments without significant disruptions.
Key Takeaways
- Market Growth: The prescription drug market is expected to grow at a CAGR of 9% through 2030.
- Price Inflation: A projected 3.81% drug price inflation rate for 2025 could impact the pricing of Myorisan.
- Regulatory Impact: ASP reporting requirements by CMS can influence pricing transparency and stability.
- Operational Considerations: Health systems need to prepare for managing costs and ensuring patient access to treatments.
FAQs
What is the current price of Myorisan (NDC 61748-303)?
The current price of Myorisan is not explicitly provided in the sources, but it can be obtained from the latest pricing data from the manufacturer or pharmacy databases.
How does drug price inflation affect Myorisan?
Drug price inflation, projected at 3.81% for 2025, could result in a similar increase in the price of Myorisan.
What regulatory requirements impact the pricing of Myorisan?
The CMS requires manufacturers to report ASP data for individual NDCs, which can influence pricing transparency and stability.
How do health systems manage the costs of drugs like Myorisan?
Health systems need to have a long-term approach to manage costs, ensure patient access, and synchronize logistics for drug administration.
What are the potential long-term price projections for Myorisan?
Long-term price projections for Myorisan will depend on market competition, regulatory changes, and demand and supply dynamics.
Sources
- CDC - IIS | Code Sets | NDC | Vaccines | CDC
- Vizient - Vizient projects drug price inflation at 3.81%
- DrugPatentWatch - Latest drug prices and trends for NDC 00054-0319
- FDA.report - NDC 61748-303 Oral Capsule, Liquid Filled Myorisan
- HHS.gov - Medicare Part B Drug Average Sales Price Reporting by Manufacturers – Blending National Drug Codes
